Board of Directors

Mike Kleine

President and Chief Executive Officer
Miramar Labs, Inc.

Mr. Kleine is currently President and Chief Executive Officer of Miramar Labs, Inc., a privately owned medical device company dedicated to bringing next generation energy modalities to the field of dermatology. Prior to joining Miramar, Mr. Kleine served as President & CEO of both EndoGastric Solutions and Biosensors International Group, a Singapore-based maker of interventional cardiology and critical care products. During his tenure at publicly traded Biosensors, he grew the market cap from $187 million to $662 million.

From 2002 to 2006, Mr. Kleine served as President and Chief Executive Officer at Microvention Inc., a leading developer, manufacturer and marketer of minimally invasive products for treatment of neurovascular and peripheral diseases. During his tenure he successfully managed the rapid growth of the company until its acquisition by Terumo Corporation in 2006.

Prior to Microvention, Mr. Kleine led a series of other medical technology companies including Pharos LLC, Thermo Cardiosystems (acquired by Thoratec), Sorin Biomedical (merged with Cobe, Inc.), and Bird Medical Technologies. Mr. Kleine’s early career includes over 13 years at Baxter in a variety of commercial roles. Mr. Kleine holds a Masters Degree from Webster University and a Bachelor of Arts in Biological Science from Missouri Valley College.